1. Anticancer activity of two novel ruthenium compounds in gastric cancer cells
   S. Ramírez-Rivera et al, 2018, Life Sciences CrossRef
2. Role of p38 MAPK in enhanced human cancer cells killing by the combination of aspirin and ABT‐737
   Chong Zhang et al, 2015, Journal of Cellular and Molecular Medicine CrossRef
3. A designer bow-tie combination therapeutic platform: An approach to resistant cancer treatment by simultaneous delivery of cytotoxic and anti-inflammatory agents and radiation
   Rakesh K. Pathak et al, 2018, Biomaterials CrossRef
4. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
   Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef
5. Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter
   Wei Jiang et al, 2020, Aging CrossRef
6. The Cytotoxicity and Synergistic Potential of Aspirin and Aspirin Analogues Towards Oesophageal and Colorectal Cancer
   Rajagopal S. Kilari et al, 2019, Current Clinical Pharmacology CrossRef
7. Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
   Tsuguru Hayashi et al, 2020, Cancers CrossRef
8. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future
   Sandra Ramos-Inza et al, 2021, Journal of Medicinal Chemistry CrossRef
9. Downregulation of BCRP and anti-apoptotic proteins by proadifen (SKF-525A) is responsible for the enhanced mitoxantrone accumulation and toxicity in mitoxantrone-resistant human promyelocytic leukemia cells
   LUCIA HIĽOVSKÁ et al, 2015, International Journal of Oncology CrossRef